Loading…

Browse All Grants

44,293 grants found

Filters
Reset

Showing 181200 of 44,293 grants

Active RESEARCH GBP
NIHR Group on Environmentally Sustainable Hospitals in Low and Middle Income Countries
National Institute for Health and Care Research University of Birmingham United Kingdom 2024 – 2028

RESEARCH QUESTION To co-develop and test interventions to decarbonise operating theatres and hospitals in low and middle income countries. BACKGROUND Climate change is an eme...

£300.55M
GBP
Active BIG BEAT CHALLENGE GBP
Curing genetic heart muscle disease (CureHeart)
British Heart Foundation University of Oxford United Kingdom 2022 – 2027

Cardiomyopathies are among the most common severe genetic diseases, occurring with a prevalence of 1 in 250 across all populations. They are the leading cause of sudden death in th...

£300M
GBP
Active PROGRAMME GRANT GBP
Translating GLP Compatible Immunomodulatory and Pro-regenerative Particles To Promote The Function Of Islets Following Transplantation In Humans.
Diabetes UK University of Nottingham United Kingdom 2024 – 2028

Islet transplantation into the liver of someone with Type 1 diabetes stabilises blood glucose control but rarely results in insulin independence, as most islets are destroyed post-...

£299.8M
GBP
Active RESEARCH GBP
Investigating the clinical and cost-effectiveness of a nutrient enriched diet for babies with a brain injury: The DOLFIN Randomised controlled trial
National Institute for Health and Care Research The Newcastle Upon Tyne Hospitals Nhs Fo... United Kingdom 2021 – 2027

Research question In babies born very pre-term or with less oxygen around the time of birth (participants), does nutritional fortification with DHA, choline and uridine-5-monophos...

£299.76M
GBP
Active DIRECTED CALL GBP
Time-restricted eating as an adjunctive intervention for bipolar disorder
Wellcome Trust Swinburne University of Technology United Kingdom 2024 – 2029

Extensive research indicates that sleep and biological rhythms are often disrupted among those with bipolar disorder (BD) and among their relatives, and that these biological rhyth...

£299.47M
GBP
Active RESEARCH GBP
Virus Genomics for Outbreak Response (ViGOR) in Central/East Africa
National Institute for Health and Care Research University of Warwick United Kingdom 2024 – 2027

Identifying effective and proportionate public health control measures for infectious disease outbreaks relies on detailed data about the pathogen, its distribution, and its transm...

£299.43M
GBP
Active RESEARCH GBP
Rapid Service Evaluation Team (RSET)
National Institute for Health and Care Research University College London United Kingdom 2023 – 2028

BACKGROUND Service or policy innovations to improve health and social care practice may be introduced rapidly, often without robust evidence. AIMS To address this, RSET will...

£298.94M
GBP
Active DISCRETIONARY AWARD GBP
Strengthening Mental Health Science II
Wellcome Trust World Health Organization, Switzerland United Kingdom 2024 – 2027

WHO proposes to strengthen mental health science relevant to its mission by developing: (1) A Flexible Diagnostic Interview tool (FLII-11) for ICD-11. Existing tools are restricted...

£298.51M
GBP
Active RESEARCH GRANT GBP
National facility for ultra-high field (11.7T) human MRI scanning
Strategic Priorities Fund University of Nottingham United Kingdom 2023 – 2028

The need for increased sensitivity and contrast drives the development of magnetic resonance imaging towards increasing magnetic field strength, with the most recent step being fro...

£298.1M
GBP
Completed RESEARCH GBP
Oral bacterial lysate to prevent persistent wheeze in infants after severe bronchiolitis; a randomised placebo controlled trial (BLIPA; Bacterial Lysate in Preventing Asthma)
National Institute for Health and Care Research Queen Mary University of London United Kingdom 2021 – 2025

Research question In infants hospitalised with bronchiolitis, does oral Broncho Vaxom (BV; a lysate of respiratory bacteria), given for 10 days per month for a total of 24 months,...

£297.4M
GBP
Active RESEARCH GBP
A Randomised Phase III Trial Comparing Intermittent with Continuous Treatment Strategies in chronic lymphocytic leukaemia (CLL)
National Institute for Health and Care Research University of Leeds United Kingdom 2021 – 2031

Design A prospective, multicentre, open-label, randomised, controlled, 2-arm, parallel-group, non-inferiority study to comparing an intermittent treatment strategy (experimental a...

£296.42M
GBP
Active DIRECTED CALL GBP
Using rTMS to enhance social cognition in people with psychosis
Wellcome Trust Feinstein Institute for Medical Research United Kingdom 2023 – 2027

In people with psychosis, deficits in social cognition are responsible for a large proportion of the functional disability associated with illness. In a previous study, we found th...

£296.28M
GBP
Active RESEARCH GBP
AIR SAFETY. A programme to prevent aerosol borne respiratory diseases using Artificial Intelligence
National Institute for Health and Care Research University College London United Kingdom 2024 – 2029

Scientific Abstract (499 words, max allowed 500 words) Research question How to enable simple user-introduced mitigations to reduce hospital airborne disease transmission by imp...

£295.83M
GBP
Active RESEARCH GBP
Mixed methods co-design and evaluation of a Decision Support Tool to enable shared decision making for people who are considering cascade screening for Thoracic Aortic Disease: The DECIDE TAD Programme.
National Institute for Health and Care Research University Hospitals of Leicester Nhs Tr... United Kingdom 2024 – 2030

Research Question: Will implementation of a Decision Support Tool improve detection of latent Thoracic Aortic Disease (TAD) through increased uptake of cascade screening in people...

£295.31M
GBP
Active ATTRIVERSE: DEVELOPING DIGITAL SOLUTIONS FOR HEALTH IMPACT ATTRIBUTION GBP
ACCLIMATISE: Attribution of a Changing CLIMate in the AssessmenT of malaria Intervention Strategy Efficiency
Wellcome Trust Universite Cheikh Anta Diop de Dakar United Kingdom 2025 – 2028

Recent significant investments in malaria interventions have reduced malaria burden. Contemporaneously, the climate has continued to warm with associated changes in rainfall and we...

£295.3M
GBP
Active RESEARCH GBP
Improving Equity in Respiratory Disease Outcomes in Africa using Data-Driven Tools: EQUI-RESP-AFRICA
National Institute for Health and Care Research The University of Edinburgh United Kingdom 2024 – 2028

Aims. An interdisciplinary group of academics, policymakers, representatives of non-governmental organisations (NGOs), patients and civil society will implement a 4-year programme...

£294.86M
GBP
Active PROGRAMME GRANT GBP
Engineering prosurvival synthetic microenvironments by modulating extrinsic and intrinsic factors in stem cell-derived islet-cells
Diabetes UK University of Oxford United Kingdom 2024 – 2028

The use of human pluripotent stem cell (SC)-derived islets holds promise as a therapy for Type 1 diabetes (T1D), but the lack of suitable conditions sustaining cell survival after...

£293.32M
GBP
Active INFRASTRUCTURE GBP
NIHR Biomedical Research Centre at The Royal Marsden NHS Foundation Trust and The Institute of Cancer Research
National Institute for Health Research The Royal Marsden Nhs Foundation Trust United Kingdom 2022 – 2027

Background Every day in the UK, over 1,000 people of all ages are diagnosed with cancer. More than half will die from this devastating disease. Many survive with long-term effects...

£292.19M
GBP
Active INTRAMURAL GBP
The Mary Lyon Centre, the national MRC facility for mouse genetics
Medical Research Council MRC Harwell United Kingdom 2022 – 2027

The Mary Lyon Centre at MRC Harwell (MLC) is the UK’s national facility for mouse genetics and the use of mouse models for the study of human disease. The specialised services avai...

£291.45M
GBP
Active RESEARCH GBP
Early Vasopressors in Sepsis (EVIS)
National Institute for Health and Care Research Nhs Greater Glasgow & Clyde United Kingdom 2021 – 2027

Population: Adults presenting to an ED, AMU or SAU with signs or symptoms of community acquired sepsis and a SBP < 90 mmHg or MAP < 65mmHg and a venous lactate of > 2mmol/l Interv...

£291.42M
GBP